Healthcare already has effective tools including medications for opioid and alcohol use disorder, but they are not being utilized widely enough. One important reason is the stigma that surrounds people with addiction
Today, NIDA issued a Request for Information (RFI) from the research community and any other interested parties regarding the establishment of a standard unit dose of THC in order to facilitate research on cannabis.
As NIDA sets its sights on new goals and objectives for 2020 and beyond, I like to reflect on how far we have come in our research efforts, especially as they concern the opioid crisis, one of the biggest public health issues of our era.
Resources and information to help you or someone you care about who might have a drug use problem.
Today, NIDA is releasing several new funding opportunity announcements related to the NIH HEAL (Helping to End Addiction Long-term ℠) Initiative.
The public health emergency of opioid misuse and addiction affects millions of Americans and requires innovative scientific solutions. Today, during “National Prescription Opioid and Heroin Awareness Week,” we are sharing news of an important step towards these solutions through the HEALing Communities Study.
Discusses effective medications used to treat opioid use disorders: methadone, buprenorphine, and naltrexone.
Tackling the opioid crisis and overdose epidemic in our nation is a task that involves partnerships among stakeholders at all levels: federal, state, and local governments and other organizations and health care systems in the community.
Presents research-based principles of adolescent substance use disorder treatment; covers treatment for a variety of drugs including, illicit and prescription drugs, alcohol, and tobacco; presents settings and evidence-based approaches unique to treating adolescents.
Subscribe to Treatment Research
This brief fact sheet provides information about the effectiveness of medications for opioid use disorders and recent scientific advances in this area.